The antibody drug benralizumab is on the fast track to becoming the first new treatment for certain kinds of asthma and COPD ...

Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease (COPD) symptoms.

A drug already used in the treatment of severe asthma could help treat exacerbations in asthma and COPD, a UK trial has found ...

Discover how benralizumab offers superior outcomes for eosinophilic asthma and COPD exacerbations, outperforming steroids in ...

Kolkata hospitals are ramping up their resources, adding beds, equipment, and personnel to address the increasing influx of patients suffering from respiratory diseases. With advanced services like ...

The clinical trial, led by scientists from King’s College London and sponsored by the University of Oxford, with support from drug firm AstraZeneca UK, was conducted at Oxford University Hospitals NHS ...

Lung Disease Therapeutics Market. The global lung disease therapeutics market is on an impressive growth trajectory, ...

Positive interim Phase 1 data indicate APG808 was well-tolerated with half-life of approximately 55 days, supporting potential for 2- to 3- month ...

Low temperatures and wintery weather can be a discouraging mix when deciding on whether to go for a run outdoors. Kerry ...

The global capnography equipment market is projected to grow from USD 334 million in 2021 to USD 536.35 million by 2032, at a ...

Apogee Therapeutics (APGE) will highlight updates from across its pipeline during its Virtual R&D Day, being held at 10:00 a.m. ET. Updates ...

NCR, there has been a huge surge in the demand for respiratory drugs like Foracort, which has emerged as the top-selling ...